BioSpace News Archive

New PSA Featuring Marvel Studios’ Heroes and Cancer Survivors to Launch April 2019

The Longest Running Cannabis Terpene Laboratory Offers New Formulation and Delivery Applications for Terpenes That Satisfy Any Application a Manufacturer Could Conceive

Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the first quarter ended March 31, 2019 on Monday, May 6, 2019.

Solera Health, an integrated benefits network, today announced the addition of four prominent business leaders to the company’s advisory board

Jaci has a rare form of childhood onset ALS called FUS P525L, that is raging in her like a wildfire.

Versiti Blood Research Institute, a national leader in blood health innovation, has been awarded a 7-year federal contract valued at $7.4 million from the U.S. Department of Health & Human Services to participate in the National Heart, Lung, and Blood Institute’s (NHLBI) research program to protect the nation’s blood supply and improve the collection and use of blood products.

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that Drs. Paul Martin and Kevin Flanigan from the Research Institute at Nationwide Children’s Hospital have completed work under a $100,000 grant exploring GALGT2 gene therapy technology as a potential treatment for Duchenne.

Need for intensive eating disorder treatment and care has increased by over 70 percent in last four years

Nearly 93 percent of all consumers are more likely to be loyal to a brand when it commits to full transparency, according to a 2017 Label Insights study from the Food Marketing Institute

Paragonix Technologies, Inc. today announced the opening of the Global Utilization And Registry Database for Improved heArt preservatioN (“GUARDIAN”) post-market registry, which will assess clinical outcomes when employing the Paragonix SherpaPak™ Cardiac Transport System (CTS) for heart transplantations.